Drug intelligence / Profile preview

Xiaoyuan Sanjie Tang

Development stage: Preclinical
Lead developer: Xiyuan Hospital
Administration: Oral, Topical

Overview

Xiaoyuan Sanjie Tang is a traditional Chinese medicine (TCM) decoction composed of six traditional Chinese medicines, including Astragalus membranaceus, Poria cocos, Xiakucao, and Shijian Chuan. It is being investigated for the treatment of non-puerperal mastitis, with preliminary exploration of its mechanism of action based on proteomics methods. The decoction is administered orally, and its residue is used for external application to the affected breast.

Beyond the preview

Go deeper on Xiaoyuan Sanjie Tang.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xiaoyuan Sanjie Tang.

Explore the full profile